SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-037471
Filing Date
2012-05-15
Accepted
2012-05-15 16:02:49
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-9682_110q.htm 10-Q 1005655
2 EX-10.1 a12-9682_1ex10d1.htm EX-10.1 309884
3 EX-31.1 a12-9682_1ex31d1.htm EX-31.1 11417
4 EX-31.2 a12-9682_1ex31d2.htm EX-31.2 11491
5 EX-32.1 a12-9682_1ex32d1.htm EX-32.1 5290
6 EX-32.2 a12-9682_1ex32d2.htm EX-32.2 5900
  Complete submission text file 0001104659-12-037471.txt   4054983

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cycc-20120331.xml EX-101.INS 419340
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycc-20120331.xsd EX-101.SCH 24035
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cycc-20120331_cal.xml EX-101.CAL 52955
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cycc-20120331_def.xml EX-101.DEF 113541
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cycc-20120331_lab.xml EX-101.LAB 374288
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycc-20120331_pre.xml EX-101.PRE 161268
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 12844508
SIC: 2834 Pharmaceutical Preparations